Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10092273 | 1.00 | CNR2 (0.32) | CNR2ALDH1A1LMNA | |
| SCHEMBL15093159 | 1.00 | CNR2 (0.32) | CNR2ALDH1A1LMNA | |
| SCHEMBL15591446 | 0.94 | CNR2 (0.32) | CNR2 | |
| SCHEMBL15424600 | 0.94 | CNR2 (0.32) | CNR2 | |
| SCHEMBL14979882 | 0.94 | CNR2 (0.32) | CNR2 | |
| SCHEMBL23394579 | 0.94 | CNR2 (0.32) | CNR2 | |
| SCHEMBL881968 | 0.94 | CNR2 (0.32) | CNR2 | |
| SCHEMBL15424484 | 0.88 | USP2 (0.30) | LMNA | |
| SCHEMBL15591610 | 0.88 | USP2 (0.30) | LMNA | |
| SCHEMBL15591611 | 0.88 | USP2 (0.30) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140017198-A1 | INHIBITORS OF HEPATITIS C VIRUS | GILEAD PHARMASSET LLC | 2014-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140017198-A1 | INHIBITORS OF HEPATITIS C VIRUS | HAVCR2, SLC10A1, GOT1 | CNR2 2867/4885ALDH1A1 112/4885LMNA 2502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.